文献速递胃肠外科

欧洲GASTRODATA注册研究中教科书式肿瘤结局的达成情况

Textbook Oncological Outcome in European GASTRODATA.
PubMed 文献 · Ann Surg · 2023-08-09

基于欧洲GASTRODATA注册研究,评估胃癌患者教科书式结局(TO)与教科书式肿瘤结局(TOO)的达成率。2558例中1700例纳入分析,TO达成1164例(68.5%),TOO达成388例(22.8%);新辅助化疗和D2或D2+淋巴结清扫对TO有正向影响。

要点

  • TO达成率为68.5%(1164/1700),TOO达成率为22.8%(388/1700)。
  • 新辅助化疗(OR=1.33,95%CI:1.04-1.70)和D2或D2+淋巴结清扫(OR=1.55,95%CI:1.15-2.10)对TO达成有正向影响。
  • 高龄、pT3/4、ASA 3/4和全胃切除对TO达成有负向影响;高龄、pT3或pT4和ASA 3或4对TOO达成有负向影响。

核心结论

  • 尽管手术结局逐步改善,但遵循当前指南的胃癌多模式治疗中,与分期相适应的化疗依从性仍然较差。
  • 进一步实施肿瘤学质量指标应更加强调围手术期化疗和充分的淋巴结清扫。

研究设计与样本

  • 基于欧洲GASTRODATA注册研究,评估胃癌患者TO和TOO达成率;2558例患者中1700例纳入分析。

主要发现

  • TO达成1164例(68.5%);TOO达成388例(22.8%)。
  • 新辅助化疗(OR=1.33,95%CI:1.04-1.70)和D2或D2+淋巴结清扫(OR=1.55,95%CI:1.15-2.10)对TO达成有正向影响。
  • 高龄(OR=0.73,95%CI:0.54-0.94)、pT3/4(OR=0.79,95%CI:0.63-0.99)、ASA 3/4(OR=0.68,95%CI:0.54-0.86)和全胃切除(OR=0.56,95%CI:0.45-0.70)对TO达成有负向影响。
  • 高龄(OR=0.37,95%CI:0.27-0.53)、pT3或pT4(OR=0.52,95%CI:0.39-0.69)和ASA 3或4(OR=0.58,95%CI:0.43-0.79)对TOO达成有负向影响。

关键数值与推荐

  • TO的判定标准为同时满足以下所有条件:无术中并发症、术者判定为根治性切除、pR0切除、至少检出15枚淋巴结、无严重术后并发症、无再干预、未入住重症监护室、无延长住院时间、无术后死亡和无再入院。
  • TOO定义为TO加上围手术期化疗依从性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the rate of textbook outcome (TO) and textbook oncological outcome (TOO) in the European population based on the GASTRODATA registry. BACKGROUND: TO is a composite parameter assessing surgical quality and strongly correlates with improved overall survival. Following the standard of treatment for locally advanced gastric cancer, TOO was proposed as a quality and optimal multimodal treatment parameter. METHODS: TO was achieved when all the following criteria were met: no intraoperative complications, radical resection according to the surgeon, pR0 resection, retrieval of at least 15 lymph nodes, no severe postoperative complications, no reintervention, no admission to the intensive care unit, no prolonged length of stay, no postoperative mortality and no hospital readmission. TOO was defined as TO with the addition of perioperative chemotherapy compliance. RESULTS: Of the 2558 patients, 1700 were included in the analysis. TO was achieved in 1164 (68.5%) patients. The use of neoadjuvant chemotherapy [odds ratio (OR) = 1.33, 95% CI: 1.04-1.70] and D2 or D2+ lymphadenectomy (OR = 1.55, 95% CI: 1.15-2.10) had a positive impact on TO achievement. Older age (OR = 0.73, 95% CI: 0.54-0.94), pT3/4 (OR = 0.79, 95% CI: 0.63-0.99), ASA 3/4 (OR = 0.68, 95% CI: 0.54-0.86) and total gastrectomy (OR = 0.56, 95% CI: 0.45-0.70), had a negative impact on TO achievement. TOO was achieved in 388 (22.8%) patients. Older age (OR = 0.37, 95% CI: 0.27-0.53), pT3 or pT4 (OR = 0.52, 95% CI: 0.39-0.69), and ASA 3 or 4 (OR = 0.58, 95% CI: 0.43-0.79) had a negative impact on TOO achievement. CONCLUSIONS: Despite successively improved surgical outcomes, stage-appropriate chemotherapy in adherence to the current guidelines for multimodal treatment of gastric cancer remains poor. Further implementation of oncologic quality metrics should include greater emphasis on perioperative chemotherapy and adequate lymphadenectomy.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Sędłak K, Rawicz-Pruszyński K, Mlak R, et al. Textbook Oncological Outcome in European GASTRODATA. Ann Surg. 2023. PMID: 37555342. doi:10.1097/SLA.0000000000006054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。